Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Btx-A51 (casein kinase inhibitor A51) | 2079068-74-7 | MFCD34469352 | 98.6% | 360.88 g·mol⁻¹ | C18H25ClN6 | 50MG
Supplier: Medchemexpress LLC HY12395450MG
BTX-A51 is a small-molecule inhibitor of casein kinase 1α (CK1α) that also shows activity against transcriptional kinases CDK7 and CDK9. Reported as orally active, it induces apoptosis in leukemia cell models and is used in preclinical studies to investigate CK1α/CDK biology. The compound is supplied as a solid powder with high analytical purity for use in biochemical, cellular, and in vivo research.
- Potent inhibitor of casein kinase 1α and transcriptional CDKs.
- Orally active with reported anti-leukemic activity.
- Induces apoptosis in leukemia cell models.
- High purity suitable for biochemical and cellular assays.
- Supplied as a solid powder, white to light yellow.
- Available in multiple pack sizes including 50 mg.
- Molecular weight 360.88 g·mol⁻¹; formula C18H25ClN6.
- Suitable for preclinical and mechanistic studies of CK1α/CDK pathways.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?